Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Feb;10(1 Suppl):S26-32.
doi: 10.1016/j.jalz.2013.12.004.

How Does Brain Insulin Resistance Develop in Alzheimer's Disease?

Affiliations
Free article
Review

How Does Brain Insulin Resistance Develop in Alzheimer's Disease?

Fernanda G De Felice et al. Alzheimers Dement. .
Free article

Abstract

Compelling preclinical and clinical evidence supports a pathophysiological connection between Alzheimer's disease (AD) and diabetes. Altered metabolism, inflammation, and insulin resistance are key pathological features of both diseases. For many years, it was generally considered that the brain was insensitive to insulin, but it is now accepted that this hormone has central neuromodulatory functions, including roles in learning and memory, that are impaired in AD. However, until recently, the molecular mechanisms accounting for brain insulin resistance in AD have remained elusive. Here, we review recent evidence that sheds light on how brain insulin dysfunction is initiated at a molecular level and why abnormal insulin signaling culminates in synaptic failure and memory decline. We also discuss the cellular basis underlying the beneficial effects of stimulation of brain insulin signaling on cognition. Discoveries summarized here provide pathophysiological background for identification of novel molecular targets and for development of alternative therapeutic approaches in AD.

Keywords: Alzheimer's disease; Amyloid-β oligomers; GLP-1R agonists; Insulin resistance; Insulin therapy.

Similar articles

See all similar articles

Cited by 73 articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback